Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. (Q36308291)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. |
scientific article |
Statements
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma (English)
Ming Shi
Bing Zhang
Zi-Rong Tang
Zhou-Yun Lei
Hui-Fen Wang
Yong-Yi Feng
Zhen-Ping Fan
Dong-Ping Xu
Fu-Sheng Wang
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference